• Eat Well Investment Group has appointed Marc Aneed, the current President and Director, as its new CEO
• Mr. Aneed has over 20 years’ experience in the consumer-packaged goods (“CPG”) space, having worked on and launched multiple successful consumer products at The Quaker Oats Company and Glanbia PLC
• Eat Well, a company that combines the best of agribusiness, food tech, and consumer goods, is building a platform that covers all the segments of the supply chain
• The company expects to leverage the guidance from its management and advisory team to grow through acquisitions, the launch of new products, expanded contracts, and more

Fully-integrated seed-to-market company Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) recently appointed the current President and Director, Marc Aneed, as its new Chief Executive Officer (“CEO”), taking over from David Doherty who has retired (https://ibn.fm/fXEuU). An award-winning natural/wellness consumer products expert with 20 years’ experience, Mr. Aneed has previously worked at The Quaker Oats Company, a PepsiCo (NASDAQ: PEP) company, and Glanbia PLC, a global nutrition company. At The Quaker Oats Company, where he started his career, Mr. Aneed worked on iconic brands such as Gatorade and more. At Glanbia PLC, where he worked before joining Eat Well, Mr. Aneed led Amazing Grass, a leading plant nutrition and supplement company boasting over $100 million in retail sales, as well as Optimum Nutrition and Isopure, Glanbia’s Sports Nutrition brands in North America. In addition, he launched multiple successful consumer products resulting in collective retail sales of over $1 billion. He has also worked on numerous M&A transactions with a total value of more than $400 million. Mr. Aneed’s appointment dovetails with the company’s strategy of leveraging the expertise and experience of the management and leadership team to achieve success within the burgeoning plant-based foods market. During an October 2021 interview with TraderTV Live (https://ibn.fm/AGp0C), Mr. Aneed noted that the leadership team, which has cumulative experience spanning over 100 years, has been instrumental in the company’s journey toward quick profitability despite being a relatively new company – Eat Well is projecting CA$60 million in final revenue for 2021. Moving forward, the company expects to continue capitalizing on the guidance provided by its advisory and management team to grow through the launch of new products, acquisitions, expanded contracts with big CPG brands that will extend its global reach, and more. “We know as a management team how to prioritize the right sorts of investments. We look at top-line revenue that’s real, that’s got use cases and velocity, and is underpinned by great gross margins. We’re not new to this space… We have a lot of the right people in our team, and… we’re bringing a lot of global leaders into this ecosystem of ours,” commented Marc. Operating in the agribusiness, food tech, and consumer goods segments, Eat Well is building a platform covering the downstream, midstream, and upstream stages of the supply chain. This holistic approach, Mr. Aneed says, matters “because supply security integrated with food tech all the way down through to retail is one of the very rare but most critical things to do in this space, and that’s what we are doing by design at Eat Well Group.” For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• Delic Corp is a leading psychedelic wellness platform with a business network which includes psychedelic wellness clinics, psilocybin research facilities, a famed psychedelic wellness event, and dedicated media and e-commerce platforms
• Delic’s CEO, Matt Stang recently joined the Gamechangers LIVE podcast to share his perspective on the development of the psychedelic industry along with Delic’s commercial evolution

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leading psychedelic wellness platform committed to bringing science-backed benefits to its many stakeholders, has long been known for its role as a trailblazer of new medicines and treatments in the current environment. Its goal is to improve access to health benefits and reframe the conversation on psychedelics. The company has sought to achieve its goals through its string of related businesses, which include Ketamine Wellness Centers, the largest chain of psychedelic wellness clinics in the country; Delic Labs, the sole entity currently licensed by Health Canada to focus exclusively on research and development of psilocybin vaporization technology; Meet Delic, the company’s eponymous psychedelic wellness event; as well as media and e-commerce platforms, Reality Sandwich, and Delic Radio. Matt Stang, Co-founder and CEO of Delic Corp recently joined the Gamechangers LIVE podcast to share his perspective on the psychedelic industry and share insights into the evolution of Delic Corp into its current form (https://ibn.fm/ab0yt). During the interview, Stang elaborated on his colorful background within the alternative drugs sector, a journey which began when he interned at High Times, a leading counterculture publication which would go on to become the voice for the cannabis industry. “I started off as an intern. It’s one of those wonderful stories. I graduated from college and wrote a senior thesis on legalization of marijuana. My thesis was that, with the terrorist attacks of 9/11, we could bring conservatives on board to legalization with a ‘tax and regulate’ strategy,” Stang said. “I submitted it to a friend who was friends with the General Counsel. He read it, loved it, and asked me to come in and intern. So, a week after I graduated, I got an internship at High Times and worked my way up…” Stang would ultimately go on to become the owner and operator of High Times, a position which he leveraged in his attempt to play a role in legalizing cannabis usage across several different states. “Now, two-thirds or more of the country live under some form of cannabis legalization… The world is changing in front of our eyes. I think the same thing is happening with psychedelics, but on a greater level and federally legal, because you have the FDA reviewing favorable clinical data for multiple psychedelics right now,” he continued. The movement to decriminalize psilocybin, the key active ingredient within psychedelic drugs, kicked off in earnest a few years ago, with Denver, Colorado becoming the first city to decriminalize psilocybin in May 2019. The cities of Oakland and Santa Cruz, California, followed suit and decriminalized psilocybin in June 2019 and January 2020, respectively (https://ibn.fm/lucZB). However, the movement has gained further momentum in recent times, with the likes of actor Will Smith commenting on his use of ayahuasca (https://ibn.fm/6vlWC), and musician Lil Nas X saying he couldn’t have written the number one album of the year without gaining inspiration from a full-day mushroom trip alongside his producers (https://ibn.fm/5N3Zs). During the podcast, Stang also went on to elaborate on the beneficial nature of psychedelic drugs and its ability to effectively supplant traditional benzodiazepines. “You’ve got tons of people stuck on Xanax or Percocet or all of these ‘maintenance’ drugs that don’t actually change you at all. You take them every day and, for the four to six hours that they’re active, you feel better. When they wear off, you feel worse,” Stang added. “With our internal data, the ketamine that we utilize is having somewhere between a 70-80% efficacy rate, meaning people are curative or better from using it for a certain period of time. With MDMA, they had a 77% rate. With psilocybin, it was closer to 80%. The full podcast interview with Delic Corp Co-Founder and CEO, Matt Stang can be found here: https://youtu.be/QIF12RiuAOQ For more information, visit the company’s website at www.DelicCorp.com and the Meet Delic conference website at www.MeetDelic.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• Flora Growth Corp. is a Canadian cannabis and wellness brand distributor operating from a cultivation base in central Colombia
• The company’s focus on sustainability guides its efforts to market products that are beneficial to their local communities as well as the world at large
• Market analysts predict 2022 will see the global CBD skin care market segment alone grow with a CAGR of 24.8 percent
• The COVID-19 pandemic is continuing to drive expansion of online retail that affects the cosmetics sector as well as clothing, groceries and other avenues that may include the more-than-190 cannabis-derivative products produced by Flora Growth

Plant-based wellness and lifestyle collective Flora Growth (NASDAQ: FLGC) is entering 2022 with momentum from the past year’s aggressive growth campaign for its global cannabis-derivative brand distribution of pharmaceuticals, cosmetics and nutraceuticals. While industry news has largely focused on M&A activity and questions about when the United States may grant federal legalization of cannabidiol (“CBD”) following the advance and then defeat of supportive banking measures in 2021, Canada-based Flora has been completing agreements with partners in numerous countries to expand its verticals from their cultivation origins in central Colombia. The COVID-19 pandemic has had a deleterious effect on the global sustainability agenda. An oil price crash made petroleum sources more attractive than alt fuels, the supply and demand of commodities faced challenges that drove price volatility, and seasonal reduction of infection levels has produced a renewed spike in environmental pollution (https://ibn.fm/vTBcC). Flora Growth has prioritized value-chain sustainability among each of its brands, acting at a local level to establish products that will have a beneficial effect on communities and the world at large under its guiding principles. Flora’s core product, organic cannabis oil, comes from an inherently natural and sustainable process at the company’s cultivation site in central Colombia, where all-outdoor production is fueled by 12.5 hours of natural sunlight per day and natural water springs. A pesticide-free agronomic management system tailored to the area’s climate and condition further ensures a natural quality to the products. The Cosechemos Cultivation Facility includes a research and development lab set on a 100-hectare (247-acre) property. The company recently began filling the initial orders for its Mind Naturals and Awe CBD skincare brands in Spain and Mexico (https://ibn.fm/XUC6A). They expect to begin a distribution of medical cannabis products throughout Europe during the coming year thanks to a pathway established through an investment program with European Union GMP partner Hoshi International Inc. (https://ibn.fm/6dFJv). European and Latin American markets for cannabis-derivative products are growing, and analysts at Allied Market Research issued a forecast shortly before Christmas that envisages the global CBD skin care market segment alone to grow from $633.6 million in 2018 to $3.48 billion by 2026 with a CAGR of 24.8 percent (https://ibn.fm/MMHht). “After months of preparation, our products meet all the needs of today’s consumers, and we are ready for new international markets. … Incorporating cutting edge formulations, rigorous safety standards and sustainable packaging, we are confident that our products are positioned to be among the best in the beauty industry,” Flora Beauty General Manager Andrew Restrepo stated when the Mind Naturals and Awe CBD orders were announced. The advance of Flora’s cosmetic brands builds on e-commerce agreements with SHOWFIELDS and GlossWire’s digital beauty marketplace, which were established in October. The Allied Market Research report anticipates growth in the e-commerce segment with a CAGR of 27.4 percent by 2026 as consumers increasingly turn to online access and distribution portals to receive products at their doorsteps. Forbes predicts that 2022 will “bring a digital revolution to retail” as department stores, chain stores and even grocery retailers see spiking sales figures in their internet sales, and CBD-based cosmetics are expected to ride that trend (https://ibn.fm/fK268). For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• FingerMotion received approval for its application for NASDAQ up-listing, and commenced trading on Tuesday, December 28, 2021, under the company’s current trading symbol, “FNGR”
• The approval marks a key milestone for the company as it plans to execute an ambitious growth strategy for the 2022 calendar year
• It marks FingerMotion’s second successful up-listing application with the first one (for the OTCQB Venture Marketplace) having gone through back in February 2019

FingerMotion (NASDAQ: FNGR) just announced listing its shares of common stocks on The Nasdaq Stock Market LLC (“Nasdaq”). The approval, which came on December 27, 2021, has seen FingerMotion become the latest technology company listed on the Nasdaq Capital Market, a move that offers the company great exposure within the investment community (https://ibn.fm/J8qfA). FingerMotion’s listing marks a significant milestone, particularly as it seeks to execute its ambitious growth strategy for the 2022 calendar year. While making the announcement, Martin Shen, the Chief Executive Officer (“CEO”) of FingerMotion, noted, “FingerMotion is very proud and excited to be joining the Nasdaq stock market as one of the newly listed technology companies.” “We believe that listing on a senior stock exchange will create more value for our shareholders, allow us to expand our investor base, and provide the opportunity to gain greater visibility for our fast-growing Company within the U.S. financial community,” he added. FingerMotion received its first upgrade back in February 2019 when it applied and got approval to trade on the OTCQB Venture Marketplace (https://ibn.fm/dLQLW). Then, in August 2021, the company submitted its application to be further up-listed on the Nasdaq Capital Market. Nasdaq trading commenced on December 28, 2021, under the current trading symbol, “FNGR.” For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• In an interview with Authority Magazine’s Charlie Katz, Rositano Jr. discussed the early years of the Fan Pass Live artist platform and how he and his brother (and business partner) found their niche with music and entertainment
• The interview includes an in-depth look at Rositano Jr.’s approach and unique business model, as well as what his role as CEO of Friendable and Fan Pass implies
• Rositano Jr. also offered valuable tips and advice for budding entrepreneurs, including the things he wished he knew before he ever became a founder

In a recent interview conducted by Charlie Katz for Authority Magazine, Robert A. Rositano Jr., co-founder, and CEO of mobile technology and marketing company Friendable (OTC: FDBL), added his story to the ongoing “5 Things I Wish Someone Told Me Before I Became A Founder” series (https://ibn.fm/86lxN). Authority Magazine offers in-depth interviews with those who hold “authority” in industries such as business, pop culture, wellness, tech, and more. Katz is the Executive Creative Director at Bitbean Software Development. In his role as the CEO, Rositano Jr. described what it is like to be an executive for the Fan Pass Live streaming platform and how it differs from other executives within the company’s infrastructure. During the interview, he summed up his role as one that requires him to “wear many hats, always staying in front of the operations and actionable items that need to happen daily, yet being hands-on enough to ensure they are being executed.” Rositano Jr. broke down his role into seven different bullet points:

• Providing customers, investors, and shareholders the painted picture and projection of the company’s vision
• Always seeking out new partners and opportunities
• Screening new ideas and concepts within team members that help to spark testing and creativity for the platform
• Being in charge of fundraising and capital raising efforts
• Driving new initiatives for revenue generation
• Reviewing, monitoring, and adjusting the company’s budget and spending continually
• Keeping track and monitoring the results

After the two discussed his role as CEO within the company, the true nature of the interview is addressed – the “5 Things I Wish Someone Told Me Before I Started.” Here is a highlight of what Rositano Jr. said in response to the question:

1. Projections are only projections – don’t begin your business on an idea (or conjectures)
2. The industry is not going to go as fast as you want it to – it’s a process
3. Always add a week of lead time to everything – even if your attorney tells you “tomorrow”
4. Keep testing (start with small audiences) and keep improving until it works
5. Don’t try to accomplish everything before you launch – you will never get off the ground

Rositano Jr. began the interview by discussing his backstory, underlining how his love of music was only the start of his passion for the music industry. It all began when he was a teenager, and his brother (and business partner) Dean Rositano formed a band in middle school. Rositano Jr. was involved in small productions, performances, and even accompanied the band to venues along the Sunset Strip in Hollywood – all before any of the members reached their 18th birthday. It was this experience that deeply instilled a love for the industry and reaffirmed that he and his brother would always have music or entertainment in their career, “no matter what.” The Fan Pass CEO also talked about how this passion for music and the industry as a whole which led to the creation of the Fan Pass platform and its focus on increasing artists’ revenue-generating opportunities while giving fans better and more affordable access to the artists they love. “We understood the amount of lost revenue each artist has, simply based on a limited number of fans who can afford or be in a particular city to attend a backstage meet & greet,” he explained. So the Rositanos approached these artists with the Fan Pass Live invention as some sort of “fly on the wall” for backstage experiences and livestream content that fans could view right from the palm of their hands/mobile device. “The concept was sound, the artists loved it and it was envisioned as a $2.99 monthly subscription (about the cost of a few songs from your favorite artist) this would create an entirely new revenue stream, as Fan Pass would be sharing a portion of the $2.99 with each artist on a recurring monthly basis,” Rositano Jr. said. Toward the conclusion of the interview, Rositano Jr. was asked about his favorite life lesson quote – “If you don’t quit… you can’t fail.” This quote has held true in many aspects of Robert’s business ventures. His lesson was learned when he was essentially sold short in his sale of “America’s Biggest,” which could have caused the company to fail – but here Friendable stands today, offering the Fan Pass artist streaming platform to help budding musicians and the fans that follow them have a universal stage to interact and showcase talent. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

Date: January 27-28, 2022 Venue: Online Livestream Dynamic Global Events (“DGE”) welcomes you to the inaugural Telemedicine Compliance Congress, an online livestream event scheduled for January 27-28, 2022. Designed for health care providers and professionals working in telemedicine companies expanding quality patient care, the extraordinary two-day event promises to provide lessons most recently learned in the field of telemedicine, especially in light of recent initiatives by regulatory and oversight bodies as well as the current complex and rapidly evolving issues facing health care providers and telemedicine companies. The COVID-19 pandemic dramatically enhanced the adoption of telemedicine, which has subsequently changed how patients receive care. It also saw many exceptions and waivers granted for telehealth regulations at the federal and state levels. With the ever-increasing proportion of the vaccinated populace, it remains unclear whether the regulatory changes that came into effect because of the pandemic will remain. Still, there is so much to explore regarding the challenges and opportunities resulting from the use of telemedicine. It is against this backdrop that the Telemedicine Compliance Congress will be held. The event will feature these and more talking points on its agenda and explore the associative challenges and opportunities. The first day will kick off with a keynote presentation entitled ‘Identify success factors for managing risk in telehealth services.’ Delivered by Kate Connelly, the Corporate Director, Enterprise Risk Management at Mass General Brigham, this presentation is designed to help stakeholders to unravel the complexities and potential risks in telehealth programs, identify their roles in risk identification and management, and acquire knowledge on how to create awareness for ethics and compliance across telehealth programs. Connelly’s presentation will kickstart a series of panel discussions, case study analyses, and presentations, spread across the two days, involving more than 15 speakers drawn from the Cincinnati Children’s Hospital Medical Center, Johns Hopkins Medicine, Northwell Health, Geisinger Health System, UPMC, CTeL, among other organizations. The speakers will cover topics such as navigating regulatory/compliance challenges in telebehavioral health, understanding the landscape for remote patient monitoring, the impact of COVID-19 on telehealth reimbursement, and an update on the state-to-state regulations and licensure and how to navigate the regulatory changes. In addition, they will discuss the barriers and potential solutions for equitable access to telemedicine, among other topics. In addition to providing insights into how to navigate the telemedicine landscape amid emerging changes, the upcoming event is packed with lessons on what stakeholders have learned throughout their telehealth journeys. It also offers an opportunity for attendees to gain strategies on what they need to help them understand their respective roles in compliance risk management and operating with integrity. The Telemedicine Compliance Congress is designed for professionals from the medical provision and telemedicine companies with responsibilities in telehealth and telemedicine, remote patient monitoring, telepsychiatry, physician services, counsel, behavioral health, privacy, compliance and regulatory affairs, risk management, surgical systems, virtual, digital, and technology. For more information, please visit https://ibn.fm/apHyC

• BevCanna Enterprises announced that its in-house brand, TRACE was designated as the exclusive water partner for the Country Music Week 2021
• The TRACE brand features a range of products sourced from springs located deep within the Rocky Mountains; the product range includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water and Natural Flavor Sparkling Spring Water among others
• BevCanna Enterprises separately announced that it has been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, recently announced that its mineral water brand, TRACE, had been designated as the exclusive water partner for the Country Music Week 2021. Hosted by the Canadian Country Music Association in London, Ontario last Nov. 26-20, the event sought to celebrate the development of the country music genre in Canada, culminating in the 2021 CCMA Awards Show, which was broadcast in a live special last Nov. 29, 2021. As the exclusive water partner of the Country Music Week 2021 and the 2021 CCMA Awards, TRACE products were available in all official welcome packages, could be found backstage at CCMA-sanctioned events and available for purchase at all main points of sale. Moreover, TRACE branding could be found on all menu listings throughout Country Music Week 2021. “We’re thrilled to partner with the CCMA on providing TRACE alkaline water for Country Music Week 2021 and the 2021 CCMA Awards,” said Melise Panetta, President of BevCanna. “As we continue to focus on expanding national awareness of the TRACE product, this is an excellent opportunity for us to reach Canadian country music fans — a growing demographic that is a strong fit for the TRACE brand.” BevCanna Enterprise’s TRACE brand features products painstakingly created using the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels. Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer several key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness. As of today, the TRACE line of products includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D, as well as Plant-Based Mineralized Immune Support Shots. BevCanna Enterprises has not rested on its laurels however, with the company recently named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada, a media company that focuses on the latest innovations, breakthroughs and greatest companies across Canada. BevCanna was also included in the list of the Top 101 Cannabis Startups and Companies in Canada, a list of innovators and growth companies within the Canadian cannabis industry (https://ibn.fm/A4tDy). “It’s both an honor and a reflection of the BevCanna team’s expertise and dedication to be included within the sphere of other premier Canadian food and beverage companies, including Ritual, Goodfood, Flow Water, Chef’s Plate and David’s Tea,” noted Marcello Leone, CEO of BevCanna. “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• Commercial aviation accounted for about 2.7% of the world’s human-induced emissions in 2019
• The aviation industry is one of the fastest growing (https://ibn.fm/Jilzk), meaning emissions will only increase in future
• To meet the targets stipulated in the Paris Agreement (https://ibn.fm/hN0cs), the industry will need to move away from fossil fuels entirely; green ammonia is emerging as one of the alternatives
• A consortium domiciled in the U.K. is developing a sustainable, low-emission propulsion system for airplanes that will use a blend of ammonia and hydrogen as a combustible fuel
• FuelPositive, through its proprietary system, produces green ammonia in a process that significantly reduces CO2 emissions associated with traditional NH3 production

According to a report by the International Council on Clean Transportation (“ICCT”), commercial aviation emitted 920 million tons of CO2 in 2019, up from 903 million tons in 2018 (https://ibn.fm/ecyqd). Based on the 2019 figure, commercial aviation accounted for about 2.7% of all human-caused emissions, considering that the CO2 emissions in 2019 totaled roughly 33 billion tons. Although aviation is a small contributor to global greenhouse emissions compared to other sectors, a BBC Future Planet article points out that it is also one of the fastest growing (https://ibn.fm/pTRE1). “With COVID-19, flights and passenger numbers plummeted, but the number of people flying is expected to return to 2019 levels within a few years and continue to grow. All this means that we need to start doing far more on aviation emissions, and fast. But bar gradually rising efficiency in planes, little progress has been made so far on how to actually decarbonize airplanes,” the article notes. Citing the Paris Agreement on climate change, which encapsulates ambitious plans to cut carbon emissions, the article states that aviation will need to move away from fossil fuels entirely in the long term to limit global warming. In line with this goal, the write-up explores several ways the industry can be kinder to the planet. These include switching the fuel to alternatives such as sustainable aviation fuels (“SAFs”) and synthetic fuels, building more efficient planes, optimizing flight routes, and, finally, enforcing policy measures. Under the alternative fuels option, green ammonia (“NH3”) has increasingly taken center stage. In August last year, a consortium made up of the United Kingdom’s Science and Technology Facilities Council (“STFC”) and Reaction Engines finalized a concept study that explored the practicality of using NH3 as a jet aviation fuel. The study paired heat exchanger technology with advanced NH3 catalysts in the hope of producing a sustainable, low-emission propulsion system (https://ibn.fm/JCZOk). According to Reaction Engines, ammonia’s energy density is high enough that planes would not require significant modifications. Designed to make ammonia use more economically viable than before, the engine (propulsion system), could be retrofitted in a relatively short time and would not require an entirely new electric powertrain. According to a New Atlas article (https://ibn.fm/IPKhX), “The heat exchanger would capture heat from a jet engine’s exhaust and use it to power a cracking reactor. The reactor would catalytically convert pure ammonia into an ammonia-hydrogen blend that’ll work as an easily combustible fuel that’s more or less a drop-in replacement for jet fuel.” Unfortunately, burning ammonia produces nitrous oxides that are harmful to the environment as they contribute to acid rain and smog formation. It is hoped that the consortium will take care of these issues in the same way FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a company committed to clean energy solutions, has dealt with the CO2 emissions linked to the generation of grey ammonia. Traditionally produced (“grey”) ammonia is generated through the Haber-Bosch process, in which nitrogen and hydrogen molecules react. This highly energy-intensive process, which consumes about 1% of the world’s total energy production, releases roughly 500 million tons of CO2 – 1.8% of total CO2 emissions from human activities globally. Yet, these figures do not even account for emissions from the on-site production of hydrogen, which is extracted from natural gas (methane) in a resource-intensive process – producing 1 ton of H2 requires 9 tons of water (https://ibn.fm/yYu4n) – that also emits large quantities of CO2. In contrast, FuelPositive’s proprietary system produces green ammonia from sustainable electricity, water, and air, at a fraction of the cost of delivering grey NH3. According to the company’s case study conducted in Manitoba, Canada, its system is about 40% cheaper (https://ibn.fm/yJlxE). In addition, it requires less energy to produce NH3 on-site, as and when needed. With the first prototype expected to be ready to deploy in the summer of 2022, researchers such as the consortium developing a propulsion system for airplanes can significantly benefit from FuelPositive’s modular and easily scalable NH3 production system. This would, in fact, conform with NHHH’s commitment to clean energy solutions, such as green ammonia, for use in a variety of applications. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• MINDCURE just announced receiving its HIPAA certification for iSTRYM, its AI-powered, SaaS platform for psychedelic therapy
• This marks a key milestone for the company, having already exceeded its target of 10 partner clinics by the end of 2021
• It also inches the company closer to the platform’s commercial deployment, set for the second quarter of 2022
• This comes just in time, following the appointment of Dr. Doron Sagman as the company’s new CMO
• MINDCURE’s Life Sciences Virtual Conference Presentation will also be available for on-demand viewing 24/7 for the next 90 days

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) has been at the forefront of the mental health industry, developing digital therapeutics and researching various psychedelic compounds. Such a blend in its approach has placed the company in a unique position to address these medical needs and stamp its position in the market. In what marks a significant leap towards commercial viability and bringing its products and services even closer to consumers, MINDCURE just announced receiving Health Insurance Portability and Accountability Act (“HIPAA”) certification for its flagship product, iSTRYM (https://ibn.fm/74y1o). iSTRYM is a software-as-a-service (“SaaS”) and artificial intelligence (“AI”)-driven platform that allows for personalized and quantified outcomes in psychedelic therapy. Through this platform, MINDCURE can modernize care, taking it from manual to digital and bringing better treatment outcomes for patients and therapists while keeping costs low for insurers. While making the announcement, Geoff Belair, MINDCURE’s Chief Technology Officer (“CTO”), noted, “We want to be the company that people trust with their minds, and achieving HIPAA is the first step of many in building that trust. At MINDCURE, we passionately defend data privacy and will ensure it is a core part of what we provide.” This HIPAA certification marks the second most significant achievement for the company’s platform, having initially exceeded the announced target of 10 partner clinics by the end of 2021. As of October, MINDCURE had over 20 partnerships with ketamine clinics in nine states in the United States and three provinces in Canada. “Our ability to partner with these clinics serves to validate our confidence in the iSTRYM platform and its value to patients and clinicians,” noted Kelsey Ramsden, the President and Chief Executive Officer (“CEO”) of MINDCURE. With the achievements so far, MINDCURE is confident that it will achieve its goal of commercially deploying the iSTRYM platform within the second quarter of the 2022 calendar year. Additionally, back in August, the company released the minimum viable product (“MVP”) of iSTRYM’s digital therapeutics technology (“DTx”). The objective was to partner with clinics across North America, a move that has yielded notable results that further inform the development of iSTRYM as it plans for the 2022 launch. “Receiving HIPAA compliance is a significant milestone for MINDCURE, which supports our goal of commercially deploying iSTRYM in the second quarter of 2022, as well as generating near-term revenue for the platform,” noted Ms. Ramsden. “We developed iSTRYM as a drug-agnostic tool that we will be able to scale beyond psychedelics and into other therapeutic fields, which could result in additional revenue opportunities for MINDCURE in the future,” she added. This certification comes just in time given the appointment of Dr. Doron Sagman as MINDCURE’s Chief Medical Officer (“CMO”). Dr. Sagman will play an integral role in furthering the company’s mission to reinvent the mental health care model for both patients and practitioners while advancing psychedelic-assisted therapy into common and accepted care (https://ibn.fm/L6JWC). Dr. Sagman lends over 18 years of experience in the pharmaceutical industry, having held leadership positions in clinical development, medical research, medical affairs, and regulatory affairs. He is excited about the industry and is delighted to be part of the MINDCURE team. “We are entering a pivotal and historical phase of medical discovery for patients who suffer from mental health disorders. I am delighted to join MINDCURE’s leadership team and work to advance innovative solutions to best meet unmet mental health needs,” he noted. On December 16, MINDCURE presented at this year’s Life Sciences Virtual Investor Conference. This year’s conference featured live presentations from CEOs and top executives who shared insights into their businesses and investment stories while also answering investors’ questions. All company presentations from the event, including MINDCURE’s, will be available 24/7 for the next 90 days, starting December 20. In addition, advisors, investors, and analysts may download shareholder materials from the company’s “virtual trade booth.” You can register or login to view the presentations here https://ibn.fm/cqG6R For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

• PlantX President and CEO Lorne Rapkin was recently part of an EDGE Podcast episode hosted by Brandon C. White, an entrepreneur and angel investor
• Lorne detailed his background and how he joined PlantX
• The interview explored the company’s growth and progress as well as the factors behind this growth, including acquisitions, marketing campaigns, and going public
• Lorne also discussed the company’s plans for the future, including adopting a franchising model and investing in warehousing facilities

Since its establishment in 2020, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a company making a mark in the global plant-based scene, has made significant strides. For instance, the company, which started with four personnel, has grown its workforce to over 75 people spread across multiple countries. One of the founding employees, Lorne Rapkin, joined host Brandon C. White, an Entrepreneur and Angel Investor, in a recent EDGE Podcast interview (https://ibn.fm/WAoJK). Lorne, who began his journey at PlantX as its Chief Financial Officer (“CFO”) before becoming its President and Chief Executive Officer (a position he holds to date), shared insights into the progress made since 2020 as well as the company’s vision and plans moving forward. Lorne started the interview by discussing his background as an entrepreneur and Certified Public Accountant (“CPA”). In this role, he amassed a lot of experience dealing with different business owners in various industries as an advisor, a position that helped him gravitate toward leading a company. When PlantX Founder Sean Dollinger, with whom he goes back many years, asked if he would be interested in taking on the CFO role to help guide the young business along the way, Lorne took him up on his offer. The company has only grown since. For instance, PlantX’s revenue increased from $1,349 to $6.5 million within the first year. Lorne credits this growth to the leadership and guidance offered by the then CEO Julia Frank (current COO). Currently, the company generates monthly recurring revenue of over $1.3 million. This growth, Lorne noted, is due to several key factors, among them acquisitions and marketing campaigns. “We have had some successful acquisitions over the past year and even into Q1 of this year – Bloombox Club UK, a juice company out of California (Little West), boutique-style grocery and food preparation company (New Deli), and a restaurant flagship store in Squamish, British Columbia (Locavore Bar & Grill). Certainly, they have helped grow the top-line revenue,” stated Lorne. “We have spent a great deal of time and resources on promoting the brand and the company through partnering with different influencers or doing out-of-the-box marketing campaigns, which has now done what we have set out PlantX to be. It’s not only offering a product but also educating the public on what is living a plant-based lifestyle… [and] also attracting the potential customers and investors to what we are truly about,” Lorne added. In addition, Lorne noted that the company’s move to go public very early on also helped its ability to scale by providing funding for the acquisitions and expansion. Using the funds, PlantX has been able to build out its e-commerce platforms, acquire companies, attract different influencers, and spend the resources needed on its website, accomplishments that are resource-intensive. Lorne also pointed out that the company ruled out traditional ways of raising capital, including taking a loan from the bank or getting funding from venture capitalists. These approaches, Lorne says, would have restricted the company’s growth trajectory to what it is today. At its core, PlantX is an e-commerce business. But the company also offers additional services, such as meal delivery, aided by its brick-and-mortar stores. “The root of our business is e-commerce, and then we have all of these new enhancements where we have flagship stores sitting in Canada, the US, and Israel, where people can come in and purchase grocery items, perishable and non-perishable goods, and plants. We are using those centers for advertising (foot traffic), warehousing and distribution, and education,” Lorne explained. PlantX intends to expand its brick-and-mortar stores business via a franchising model. First, the company plans to establish flagship stores in specific locations – it expects to open new stores in Los Angeles and Israel later in December. Next, PlantX will help people learn about the stores and then sell franchise licenses. Already, there are different interested parties. “If we can show people that this brick-and-mortar model is very attractive; we will have a variety of products – it’s not all going to be food – fitting in these respective stores, which we know will do well just based on our acquisition of New Deli in Venice. We know that there’s a demand, we know what the top-line revenue and margins are, and we know that there’s a great ability to get the businesses to where they need to be, to be profitable,” Lorne continued. Moving forward, the company intends to focus on groceries as the next phase of growth. As a result, PlantX is investing in warehousing facilities, which will allow it to achieve more real-time and efficient deliveries. The company has already secured several strategically located warehouses in Canada and the United States. At the same time, PlantX will also concentrate on its e-commerce business as well as brick-and-mortar stores under the franchising model. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF